These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 28025030)

  • 1. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis.
    Wu L; Chen L; Li L
    Clin Chim Acta; 2017 Mar; 466():78-84. PubMed ID: 28025030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological role of apelin in angiogenic eye disease].
    Kasai A
    Yakugaku Zasshi; 2011; 131(8):1201-6. PubMed ID: 21804324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apelin/APJ system and cancer.
    Yang Y; Lv SY; Ye W; Zhang L
    Clin Chim Acta; 2016 Jun; 457():112-6. PubMed ID: 27083318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of the apelin-APJ axis in vascular formation.
    Kidoya H; Takakura N
    J Biochem; 2012 Aug; 152(2):125-31. PubMed ID: 22745157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of apelin on ischemia/reperfusion injury.
    Yang Y; Lv SY; Lyu SK; Wu D; Chen Q
    Peptides; 2015 Jan; 63():43-6. PubMed ID: 25447414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
    O'Carroll AM; Lolait SJ; Harris LE; Pope GR
    J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin/APJ signaling in hypoxia-related diseases.
    He L; Xu J; Chen L; Li L
    Clin Chim Acta; 2015 Dec; 451(Pt B):191-8. PubMed ID: 26436483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis.
    Kälin RE; Kretz MP; Meyer AM; Kispert A; Heppner FL; Brändli AW
    Dev Biol; 2007 May; 305(2):599-614. PubMed ID: 17412318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes.
    Kunduzova O; Alet N; Delesque-Touchard N; Millet L; Castan-Laurell I; Muller C; Dray C; Schaeffer P; Herault JP; Savi P; Bono F; Valet P
    FASEB J; 2008 Dec; 22(12):4146-53. PubMed ID: 18708591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The apelin-APJ axis: A novel potential therapeutic target for organ fibrosis.
    Huang S; Chen L; Lu L; Li L
    Clin Chim Acta; 2016 May; 456():81-88. PubMed ID: 26944568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.
    Lv D; Li H; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):527-33. PubMed ID: 23588025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apelin-APJ system: from discovery to therapeutic target].
    Kasai A
    Nihon Yakurigaku Zasshi; 2012 May; 139(5):198-202. PubMed ID: 22687871
    [No Abstract]   [Full Text] [Related]  

  • 14. Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury.
    Chen Z; Wu D; Li L; Chen L
    DNA Cell Biol; 2016 Dec; 35(12):766-775. PubMed ID: 27854125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The APJ receptor: a new therapeutic approach in diabetic treatment].
    Masri B; Dray C; Knauf C; Valet P; Castan-Laurell I
    Med Sci (Paris); 2015 Mar; 31(3):275-81. PubMed ID: 25855281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APJ/apelin: A promising target for the treatment of retinopathy of prematurity.
    Su J; Zhang Y; Kumar SA; Sun M; Yao Y; Duan Y
    Drug Discov Today; 2022 Aug; 27(8):2342-2352. PubMed ID: 35561966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo.
    Cox CM; D'Agostino SL; Miller MK; Heimark RL; Krieg PA
    Dev Biol; 2006 Aug; 296(1):177-89. PubMed ID: 16750822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely.
    Sun X; Iida S; Yoshikawa A; Senbonmatsu R; Imanaka K; Maruyama K; Nishimura S; Inagami T; Senbonmatsu T
    Hypertens Res; 2011 Jun; 34(6):701-6. PubMed ID: 21412239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apelin is a crucial factor for hypoxia-induced retinal angiogenesis.
    Kasai A; Ishimaru Y; Kinjo T; Satooka T; Matsumoto N; Yoshioka Y; Yamamuro A; Gomi F; Shintani N; Baba A; Maeda S
    Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2182-7. PubMed ID: 20705920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin/APJ system: A novel potential therapy target for kidney disease.
    Huang Z; Wu L; Chen L
    J Cell Physiol; 2018 May; 233(5):3892-3900. PubMed ID: 28796300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.